- Home
- GREE vs INDP Comparison
GREE vs INDP Comparison
Compare GREE & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GREE
- INDP
- Stock Information
- Founded
- GREE 1937
- INDP 2000
- Country
- GREE United States
- INDP United States
- Employees
- GREE N/A
- INDP N/A
- Industry
- GREE Investment Bankers/Brokers/Service
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- GREE Finance
- INDP Health Care
- Exchange
- GREE Nasdaq
- INDP Nasdaq
- Market Cap
- GREE 9.8M
- INDP 8.8M
- IPO Year
- GREE N/A
- INDP N/A
- Fundamental
- Price
- GREE $0.76
- INDP $0.50
- Analyst Decision
- GREE Strong Buy
- INDP Strong Buy
- Analyst Count
- GREE 1
- INDP 2
- Target Price
- GREE $4.00
- INDP $8.50
- AVG Volume (30 Days)
- GREE 137.2K
- INDP 1.2M
- Earning Date
- GREE 05-14-2025
- INDP 03-13-2025
- Dividend Yield
- GREE N/A
- INDP N/A
- EPS Growth
- GREE N/A
- INDP N/A
- EPS
- GREE N/A
- INDP N/A
- Revenue
- GREE $59,533,000.00
- INDP N/A
- Revenue This Year
- GREE N/A
- INDP N/A
- Revenue Next Year
- GREE N/A
- INDP N/A
- P/E Ratio
- GREE N/A
- INDP N/A
- Revenue Growth
- GREE N/A
- INDP N/A
- 52 Week Low
- GREE $0.71
- INDP $0.47
- 52 Week High
- GREE $3.84
- INDP $3.10
- Technical
- Relative Strength Index (RSI)
- GREE 35.62
- INDP 24.26
- Support Level
- GREE $0.71
- INDP $0.58
- Resistance Level
- GREE $0.90
- INDP $0.78
- Average True Range (ATR)
- GREE 0.07
- INDP 0.14
- MACD
- GREE 0.01
- INDP -0.03
- Stochastic Oscillator
- GREE 18.20
- INDP 1.89
About GREE Greenidge Generation Holdings Inc.
Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center and power generation company. The company owns and operates facilities at two locations: the Town of Torrey, New York, and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.